Jeffrey Gordon

Coming Soon!

Caroline Dehart

Caroline DeHart leads the mass spectrometry group within the NCI RAS Initiative at the Frederick National Laboratory for Cancer Research. She received a B.S. in Biochemistry and Molecular Biology from the University of Maryland, Baltimore County, along with an M.A. and Ph.D. in Molecular Biology from Princeton University (laboratory of Jane Flint). She also completed postdoctoral training at Northwestern University (laboratory of Neil Kelleher) and the National High Magnetic Field Laboratory (laboratory of Christopher Hendrickson) before serving as the Director of Cancer Proteomics for the National Resource for Translational and Developmental Proteomics at Northwestern University. Her current research focuses on employing top-down proteomics to better understand intact and modified protein forms (proteoforms) and post-translational modifications of endogenous RAS proteins within various cancer contexts. Her group also employs a combination of global, targeted, top-down, native, and crosslinking-based proteomic workflows to support internal and external RAS Initiative collaborative projects with the goal of better understanding (and inhibiting) RAS-dependent signaling in human cancer.

Julia Laskin

Julia Laskin is the William F. and Patty J. Miller Professor of Analytical Chemistry at Purdue University. Her research is focused on the development of mass spectrometry-based instrumentation and experimental approaches for selective modification of substrates using beams of mass-selected ions and for quantitative molecular imaging of biological samples. Dr. Laskin obtained her M.Sc. in Physics from the Leningrad Polytechnical Institute (1990) and Ph.D. in Physical Chemistry from the Hebrew University of Jerusalem (1998) with Prof. Chava Lifshitz. She did her postdoctoral research with Dr. Jean Futrell at the University of Delaware and Pacific Northwest National Laboratory (PNNL). Prior to joining Purdue in 2017, she was a scientist at PNNL (2002-2017) and was promoted to the highest scientific rank in 2011. Dr. Laskin's research has resulted in over 320 peer-reviewed publications including invited reviews and book chapters and 11 patents. She is Past President of the American Society for Mass Spectrometry (ASMS) and an editor-in-chief of the International Journal of Mass Spectrometry. She was Vice President for Programs and President of the ASMS, a co-organizer of the 2019 ASMS Asilomar Conference on Imaging Mass Spectrometry, and a chair of the 2017 Gordon Research Conference on Gaseous Ions.Her research has been honored with several prestigious awards including Presidential Early Career Award (2007), ASMS Biemann Medal (2008), Inaugural Rising Star Award of the ACS Women Chemists Committee (2011), PNNL Director's Science and Engineering Achievement Award (2014), Medal of the Russian Society for Mass Spectrometry (2017), the Ron Hites Award (2019), The Riveros Medal of the Brazilian Mass Spectrometry Society (2022), Advances in Measurement Science Lectureship Award (2023), ACS Chemical Instrumentation Award (2025), and other.

Josh Sharp

Professor Sharp is an internationally recognized expert in radical protein footprinting (RPF). He has published more than forty peer-reviewed articles in the field of RPF method development, fundamentals, and applications between 2002 and today. Professor Sharp published the first benchtop methods for HRPF, including the first method using UV photolysis of hydrogen peroxide for RPF. With numerous invited lectures to both academia and private industry on the application of HRPF to biotherapeutics and disease, Dr. Sharp has addressed problems associated with formulation, biosimilarity, aggregation, and protein-protein and protein-ligand interaction mapping. Professor Sharp received his PhD in 2003 under the mentorship of Dr. Robert Hettich of Oak Ridge National Laboratory and the University of Tennessee. He performed his postdoctoral studies at the National Institute of Environmental Health Sciences in the Laboratory of Structural Biology, under the supervision of Dr. Kenneth Tomer. In 2007, he joined the University of Georgia's Complex Carbohydrate Research Center as a research faculty member. Most recently, Professor Sharp joined the faculty at the University of Mississippi School of Pharmacy, where he currently serves as the Triplett-Behrakis Professor of Pharmacology, Joint Professor of Chemistry and Biochemistry, and Director of the Glycoscience Center of Research Excellence. Professor Sharp is also an active entrepreneur, serving as founder, CTO and Director of GenNext Technologies, Inc. He has received multiple awards for excellence in research, winning the Cumberland Pharmaceuticals Faculty Research Award from the University of Mississippi School of Pharmacy, and the Ron Hites Award from the American Society for Mass Spectrometry.

Chris Whelan

Dr. Chris Whelan received his Ph.D. in Diagnostics & Therapeutics for Human Disease from the Royal College of Surgeons in Ireland and completed a post-doctoral fellowship with Professor Paul Thompson at the University of Southern California. He has spent almost a decade in roles of increasing seniority in biopharma, including R&D leadership positions at Pfizer, Biogen and Johnson & Johnson. Chris has founded and led multiple scientific consortia, including ENIGMA-Epilepsy and the UK Biobank Pharma Proteomics Project (UKB-PPP). He currently works with multiple large pharmas, biotech start-ups and VC incubators in his role as Managing Director of Ignition Scientific, and is building a stealth proteomics & population health biotech to be announced over the coming months.

Anne-Claude Gingras

Coming Soon!

Scott Matson

Dr. Matson studied medicine (MD 2013) at the University of Kansas School of Medicine. Following graduation, he completed residency and chief medical residency in internal medicine at the University of Colorado in Denver. He completed a combined pulmonary and critical care fellowship at the University of Colorado and National Jewish Hospital. During his fellowship, Dr. Matson pursued advanced clinical and research training in interstitial lung disease. At the University of Kansas, Dr. Matson sees patients in the Interstitial Lung Disease and Rare Lung Disease clinic as well as attends in the medical intensive care unit and serves as associate program director for the pulmonary critical care fellowship and directs the fellowship research program. He is a clinician scientist whose research lab has received funding from the NIH, NHLBI, NIGMS, the American Lung Association, Pulmonary Fibrosis Foundation, and the Rheumatology Research Foundation. The Matson lab leverages systems biology and quantitative imaging analysis to develop treatment prediction tools to better understand the role of immunosuppression across etiologies of ILD. In 2024, Dr. Matson founded and now directs the KUMC Autoimmune Lung Disease Clinic, a joint effort between pulmonary and rheumatology divisions at KU that manages complex patients in the region and serves as a hub for clinical trials and research efforts for these patients.

Bruce Wilcox

Bruce E. Wilcox, Ph.D is Chief Technology Officer at PrognomiQ. He received his Ph.D. from University of New Mexico and completed a post-doc at the NHMFL. Dr. Wilcox's career with mass spectrometry began with novel instrument designs prior to transitioning to large scale plasma proteomics biomarker discovery resulting in the development of multiple commercial clinical tests. Dr. Wilcox's team at PrognomiQ has developed a comprehensive multi-omics biomarker discovery platform utilizing genomics, transcriptomics, metabolomics and proteomics to conduct large scale discovery studies that have identified, and translated to the clinic, blood-based biomarkers for early lung cancer detection.

Peder Lund

Dr. Peder Lund holds a BS in Medical Microbiology and Immunology from the University of Wisconsin and a PhD in Immunology from Stanford University. For his thesis research, he worked with Dr. Mark Davis to investigate how modification of proteins with O-linked N-acetylglucosamine, an atypical form of glycosylation that occurs on intracellular proteins, functions in the regulation of T cell activation. He then pursued post-doctoral training in epigenetics, host-microbiota interactions, and mass spectrometry at the University of Pennsylvania and Washington University in St. Louis with Dr. Benjamin Garcia. Currently, Dr. Lund is a faculty member in the Nutrition Department at Case Western Reserve University, where he applies mass spectrometry and other approaches to understand how metabolic interactions between the gut microbiota and intestinal epithelial cells maintain tissue homeostasis, deficiencies in which may contribute to the development of inflammatory bowel disease.

Alexey Nesvizhskii

Coming Soon!

Derrick Morton

Dr. Derrick Morton is a tenure-track Assistant Professor at the University of Southern California in the Department of Biological Sciences. He earned his Ph.D. from Clark Atlanta University and completed a postdoctoral fellowship at Emory University. His research program investigates RNA-mediated regulatory mechanisms critical for the development and function of the nervous system in higher eukaryotes. Understanding RNA-regulatory events is important for nervous system development and function, as defects in ubiquitously expressed RNA surveillance factors disproportionately cause severe neurodevelopmental disorders (NDDs). Specifically, his laboratory investigates the role of the RNA-regulatory RNA exosome in neuronal differentiation and homeostasis by exploring the effects of pathogenic RNA exosome mutations linked to distinct NDDs. Employing high-throughput transcriptomics, molecular genetics, and imaging techniques in Drosophila and human iPSC-derived brain organoids, Dr. Morton's research is at the center of an emerging RNA-centric neuroscience field.

Keenan Walker

Coming Soon!

Ying Ge

Dr. Ying Ge is the Vilas Distinguished Achievement Professor of Cell & Regenerative Biology and Chemistry at the University of Wisconsin-Madison. She also serves as the Director of the Human Proteomics Program. Dr. Ge's research is highly interdisciplinary that cuts across the traditional boundaries of chemistry, biology, and medicine. She is passionate about translating bench discoveries to the clinic for precision medicine. Specifically, Dr. Ge's research focuses on top-down mass spectrometry (MS)-based proteomics, with applications in cardiovascular biology and precision medicine. Her lab develops innovative methods for protein solubilization, multi-dimensional chromatography, and high-sensitivity MS techniques to characterize proteoforms. Dr. Ge has published over 200 papers and has received multiple prestigious awards, including the ASMS Biemann Medal and the HUPO Clinical and Translational Proteomics Sciences Award, as well as the Top 10 Analytical Scientist Power List (in North America, 2020), and recently Top 20 Human Health Heros.

Karine Le Roch

Dr. Karine Le Roch has over 25 years of experience in drug discovery and functional genomics of eukaryotic pathogens, with a primary focus on Plasmodium, the parasite responsible for malaria. She earned her B.A. in Biochemistry and Chemistry from the University of Paris-Sorbonne in 1995 and a Master's in Parasitology in 1997 at the University of Lille II and the University of Oxford, where she characterized molecular components of Pneumocystis carinii, an opportunistic pathogen. Dr. Le Roch received her Ph.D. in 2001 from the University of Paris-Sorbonne focusing on cell cycle regulation and protein kinases in Plasmodium. She then joined The Scripps Research Institute as a postdoctoral fellow with Prof. E. Winzeler, pioneering functional genomics studies in malaria parasites. In 2004, she joined the Genomics Institute of the Novartis Research Foundation (GNF) as a Research Fellow, where she established its malaria drug discovery program. Since joining the University of California, Riverside (UCR) in 2006, Dr. Le Roch, now a full Professor, has led a laboratory developing high-throughput genomics and proteomics approaches to investigate epigenetic, chromatin, and transcriptional mechanisms that regulate parasite gene expression. She has authored over 130 peer-reviewed publications, 16 book chapters, and holds three U.S. patents. Since 2016, Dr. Le Roch has also served as Director of the UCR Center for Infectious Disease and Vector Research (cidvr.ucr.edu).

Ben Orsburn

Ben Orsburn is a biologist and mass spectrometrist best known as a scientific communicator, blogger and now - somehow, podcast host. After a decade or something in industry he took a chance on academia again. He is now an Assistant Professor at the University of Pittsburgh in the Organ Pathobiology and Therapeutics Institute. His team leverages low input and single cell proteomics to accelerate the deployment of new clinical diagnostics.